Pancreatic cancer stem cells: A state or an entity?

Area of Science:

• Oncology
• Cancer Biology
• Gastroenterology

Background:

• Pancreatic ductal adenocarcinoma (PDAC) has poor survival rates, with less than 7% 5-year survival.
• PDAC is the 4th leading cause of cancer death globally and projected to be the 2nd by 2030.
• Cancer stem cells (CSCs) contribute to PDAC's chemoresistance and metastasis.

Purpose of the Study:

• To review the characteristics of pancreatic CSCs and their niche.
• To explore the interactions between CSCs and niche cells.
• To discuss the implications of CSCs as states versus entities for treatment.

Main Methods:

• Review of existing literature on pancreatic cancer stem cells.
• Analysis of CSC properties, including self-renewal, metabolism, and chemoresistance.
• Examination of the CSC niche and cell-cell interactions.
• Discussion of current therapeutic limitations and future directions.

Main Results:

• Pancreatic CSCs possess unique properties enabling self-renewal and treatment evasion.
• CSCs are increasingly viewed as dynamic states rather than fixed entities.
• The CSC niche plays a critical role in maintaining the CSC population.
• Current treatments fail to effectively target the plastic CSC sub-population.

Conclusions:

• Targeting pancreatic CSCs and their niche is essential for improving PDAC patient survival.
• Understanding CSC plasticity is key to developing novel therapeutic strategies.
• Further research into CSC-niche interactions will inform future treatment approaches.